138 related articles for article (PubMed ID: 35980780)
1. Relationships Between Serum Cortisol, RAGE-Associated s100A8/A9 Levels, and Self-Reported Cancer-Related Distress in Women With Nonmetastatic Breast Cancer.
Taub CJ; Diaz A; Blomberg BB; Jutagir DR; Fisher HM; Gudenkauf LM; Lippman ME; Hudson BI; Antoni MH
Psychosom Med; 2022 Sep; 84(7):803-807. PubMed ID: 35980780
[TBL] [Abstract][Full Text] [Related]
2. The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment.
Taub CJ; Lippman ME; Hudson BI; Blomberg BB; Diaz A; Fisher HM; Nahin ER; Lechner SC; Kwak T; Hwang GH; Antoni MH
Cancer; 2019 May; 125(10):1717-1725. PubMed ID: 30633331
[TBL] [Abstract][Full Text] [Related]
3. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
[TBL] [Abstract][Full Text] [Related]
4. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models.
Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS
Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
[TBL] [Abstract][Full Text] [Related]
6. Stress-induced release of the S100A8/A9 alarmin is elevated in coronary artery disease patients with impaired cortisol response.
Jonasson L; Grauen Larsen H; Lundberg AK; Gullstrand B; Bengtsson AA; Schiopu A
Sci Rep; 2017 Dec; 7(1):17545. PubMed ID: 29235502
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
8. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
9. Association Between Clinicopathological Parameters and S100A8/A9 Expression According to Smoking History in Patients With Non-small Cell Lung Cancer.
Cho SB; Kim IK; Yeo CD; Lee SH
In Vivo; 2024; 38(1):474-481. PubMed ID: 38148054
[TBL] [Abstract][Full Text] [Related]
10. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
11. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
12. S100A8/A9: From basic science to clinical application.
Pruenster M; Vogl T; Roth J; Sperandio M
Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
[TBL] [Abstract][Full Text] [Related]
13. Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits.
Drosatos IA; Tsoporis JN; Izhar S; Gupta S; Tsirebolos G; Sakadakis E; Triantafyllis AS; Rigopoulos A; Rigopoulos D; Rallidis LS; Rizos I; Parker TG
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572568
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells.
Wang L; Luo H; Chen X; Jiang Y; Huang Q
PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267
[TBL] [Abstract][Full Text] [Related]
15. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
[TBL] [Abstract][Full Text] [Related]
16. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
17. exMCAM-Fc, an S100A8/A9-mediated-metastasis blocker, efficiently reduced the number of circulating tumor cells that appeared in the blood flow.
Tomonobu N; Kinoshita R; Sakaguchi M
Mol Biol Rep; 2020 Jun; 47(6):4879-4883. PubMed ID: 32383137
[TBL] [Abstract][Full Text] [Related]
18. DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes.
Sakaguchi M; Murata H; Aoyama Y; Hibino T; Putranto EW; Ruma IM; Inoue Y; Sakaguchi Y; Yamamoto K; Kinoshita R; Futami J; Kataoka K; Iwatsuki K; Huh NH
J Biol Chem; 2014 Aug; 289(34):23389-402. PubMed ID: 25002577
[TBL] [Abstract][Full Text] [Related]
19. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.
Ghavami S; Rashedi I; Dattilo BM; Eshraghi M; Chazin WJ; Hashemi M; Wesselborg S; Kerkhoff C; Los M
J Leukoc Biol; 2008 Jun; 83(6):1484-92. PubMed ID: 18339893
[TBL] [Abstract][Full Text] [Related]
20. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]